ganoderic acid B,
Ganoderic acid B,
81907-61-1,
UNII-AV74TFJ3IS,
AV74TFJ3IS,
(2R,6R)-6-((3S,5R,7S,10S,13R,14R,17R)-3,7-Dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid,
(2r,6r)-6-[(3s,5r,7s,10s,13r,14r,17r)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid,
(2R,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid,
AC1LAM6U,
CTK5E9201,
Lanost-8-en-26-oic acid, 3,7-dihydroxy-3,11,23-trioxo-, (7.beta.,15.alpha.,25R)-,
Lanost-8-en-26-oicacid, 3,7-dihydroxy-11,15,23-trioxo-, (3b,7b,25R)-,
MFCD09752803,
ZINC49777990,
AKOS027338661,
AN-36215,
FT-0699024,
907G611,
Lanost-8-en-26-oic acid, 3,7-dihydroxy-3,11,23-trioxo-, (7beta,15alpha,25R)-,
CID471003,
ACN-047175,